Organization
University of Sydney, Sydney, Australia
1 abstract
Abstract
NADOM trial: Neoadjuvant/adjuvant trial of darovasertib in ocular melanoma (OM).Org: Royal Victorian Eye and Ear Hospital, Melbourne, Australia, University of Sydney, Sydney, Australia, Princess Alexandra Hospital, Greenslopes Private Hospital and University of Queensland, Brisbane, Australia, Queensland Institute of Medical Research Berghofer, Herston, Australia, Terrace Eye Centre, Brisbane, Australia,